Cytosorbents Corporation
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $6.2M | $3.3M | $14.1M | $22.1M | $52.1M | $71.4M | $12.2M | $22.4M |
| Accounts Receivable | $7.6M | $7.3M | $6.1M | $5.7M | $4.5M | $5.2M | $4.5M | $3.9M |
| Inventory | $5.3M | $2.7M | $3.4M | $3.5M | $4.8M | $2.7M | $2.1M | $833.1K |
| Total Current Assets | $20.6M | $21.6M | $25.4M | $33.8M | $64.3M | $82.5M | $20.9M | $28.3M |
| Property, Plant & Equipment | $7.8M | $9.0M | $10.1M | $10.7M | $5.2M | $2.1M | $1.9M | $1.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $3.2M | $3.7M | $3.9M | $4.4M | $4.7M | $4.2M | $3.4M | $2.6M |
| Total Assets | $44.2M | $47.4M | $53.0M | $63.2M | $89.5M | $90.0M | $27.4M | $34.2M |
| Liabilities | ||||||||
| Accounts Payable | $2.9M | $3.3M | $3.8M | $1.7M | $2.8M | $1.8M | $2.0M | $1.5M |
| Total Current Liabilities | $9.7M | $9.8M | $14.0M | $9.7M | $13.7M | $10.2M | $9.9M | $6.9M |
| Long-Term Debt | $16.7M | $14.0M | $2.5M | $5.0M | — | $0 | $13.4M | $9.3M |
| Total Liabilities | $38.3M | $36.3M | $29.5M | $27.9M | $26.9M | $10.7M | $24.0M | $17.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-312.2M | $-304.0M | $-283.3M | $-254.0M | $-221.2M | $-196.6M | $-188.8M | $-169.5M |
| Total Stockholders' Equity | $5.9M | $11.1M | $23.5M | $35.4M | $62.6M | $79.2M | $3.4M | $16.9M |